Furthermore, the fecal transplantation from melanoma patients responding to ICI to germ-free mice led to a better response to anti-PD-1 therapy as compared to mice, receiving gut transplants from non-responding patients [80]. The gene discussed is PDCD1; the disease is melanoma.